Organon CEO Uncertain Over Long-Term Future Of Biosimilars Business

Kevin Ali: ‘I Don't Know Where The Biosimilar Business Will Be In The Next Decade’

 
• By David Wallace
  
Crystal ball with blue smoke, uncertainty concept
Organon: The long-term future of the biosimilars business is unclear • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products